Trials that use: Risk difference
New to this method? Read the tutorial →
6,276 results
- Maraviroc as GVHD Prophylaxis in Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Maraviroc as GVHD Prophylaxis in Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02167451).
- Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00948753).
- Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MARRSIndependent statistical analysis of Millipede AspiRation for Revascularization in Stroke (MARRS) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05714501).
- MARSIndependent statistical analysis of Microvascular Flow Assessment Repeatability Study: The MARS Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01242020).
- MARSIndependent statistical analysis of Project MARS: Mobile-Assistance for Regulating Smoking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04376489).
- MARS GIIndependent statistical analysis of Safety and Feasibility of the Use of the Dual Robotic Arm Accessory With the Levita Magnetic Surgical System in Laparoscopic Procedures: primary endpoint results, effect estimate with confidence…
- MASCIIndependent statistical analysis of Allogeneic SCT Of Pts With SCID And Other Primary Immunodeficiency Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Mass-balance Study of [14C]-APD421 in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Mass-balance Study of [14C]-APD421 in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02881840).
- Massive Iron Deposit Assessment: Complete Statistical AnalysisIndependent statistical analysis of Massive Iron Deposit Assessment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01572922).
- Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE: Complete Statistical AnalysisIndependent statistical analysis of Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MASTIndependent statistical analysis of MAST Trial: Multi-modal Analgesic Strategies in Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03472469).
- Mast Cell Activation Test in Allergic Disease: Complete Statistical AnalysisIndependent statistical analysis of Mast Cell Activation Test in Allergic Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03406325).
- Mastectomy Flap Temperature Study: Complete Statistical AnalysisIndependent statistical analysis of Mastectomy Flap Temperature Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05395936).
- MasterKey-01Independent statistical analysis of A Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- MATCh-GDMIndependent statistical analysis of Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03029702).
- MATOCSSIndependent statistical analysis of Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Mature B-Cell Lymphoma And Leukemia Study III: Complete Statistical AnalysisIndependent statistical analysis of Mature B-Cell Lymphoma And Leukemia Study III: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01046825).
- MAVISIndependent statistical analysis of Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation: Complete Statistical AnalysisIndependent statistical analysis of Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MAXIMIZAIndependent statistical analysis of Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza…
- MBCT Delivered Via Group Videoconferencing for ACS Patients With Elevated Depression Symptoms: Complete Statistical AnalysisIndependent statistical analysis of MBCT Delivered Via Group Videoconferencing for ACS Patients With Elevated Depression Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MBTAIndependent statistical analysis of Develop and Validation of Measurement-Based Transition Assistance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05384171).
- MCAPIndependent statistical analysis of HIV Prevention Toolkit for HIV-negative Male Couples: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02494817).
- MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery: Complete Statistical AnalysisIndependent statistical analysis of MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MDX1106-01Independent statistical analysis of A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MEASURE 1 extIndependent statistical analysis of Extension in AS: Sustainability of Benefits, Safety and Tolerability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01863732).
- Measurement of Relaxin Peptide in Multiple Sclerosis (MS): Complete Statistical AnalysisIndependent statistical analysis of Measurement of Relaxin Peptide in Multiple Sclerosis (MS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01909492).
- Measuring Dysphagia After ACDF Surgery Through A Novel Wearable Sensor: Complete Statistical AnalysisIndependent statistical analysis of Measuring Dysphagia After ACDF Surgery Through A Novel Wearable Sensor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04921800).
- Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRI: Complete Statistical AnalysisIndependent statistical analysis of Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04097535).
- Measuring Gait And Self-Reported Pain In Patients With Osteoarthritis Of The Knee Using Placebo/Oxycodone/Celecoxib.: Complete Statistical AnalysisIndependent statistical analysis of Measuring Gait And Self-Reported Pain In Patients With Osteoarthritis Of The Knee Using Placebo/Oxycodone/Celecoxib.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Measuring the Amount of Methadone or Morphine in the Blood of Neonates, Infants & Children After Cardiac Surgery.: Complete Statistical AnalysisIndependent statistical analysis of Measuring the Amount of Methadone or Morphine in the Blood of Neonates, Infants & Children After Cardiac Surgery.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Mechanisms of Chronic Kidney Disease (CKD)-Induced Foam Cell Formation: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Chronic Kidney Disease (CKD)-Induced Foam Cell Formation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01671605).
- MeCISIndependent statistical analysis of MethaCholine Bronchoprovocation Study (MeCIS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00705341).
- MEDALISTIndependent statistical analysis of A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MEDEXIndependent statistical analysis of A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Medtronic MiniMed Implantable Insulin Pump: Complete Statistical AnalysisIndependent statistical analysis of Medtronic MiniMed Implantable Insulin Pump: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00298740).
- Medtronic Resolute Onyx 2.0 mm Clinical Study: Complete Statistical AnalysisIndependent statistical analysis of Medtronic Resolute Onyx 2.0 mm Clinical Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02412501).
- MEK InhibitorIndependent statistical analysis of MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02096471).
- MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma: Complete Statistical AnalysisIndependent statistical analysis of MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC): Complete Statistical AnalysisIndependent statistical analysis of MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mel47Independent statistical analysis of Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mel55Independent statistical analysis of Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Melatonin for Circadian Sleep Disorders in the Blind: Complete Statistical AnalysisIndependent statistical analysis of Melatonin for Circadian Sleep Disorders in the Blind: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00911053).
- Melatonin Postoperative Sleep Study in Breast Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Postoperative Sleep Study in Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00506064).
- Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men: Complete Statistical AnalysisIndependent statistical analysis of Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MENDEL-2Independent statistical analysis of Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2: primary endpoint results, effect estimate with confidence interval, sample-size…
- Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS): Complete Statistical AnalysisIndependent statistical analysis of Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00805935).
- MERCURIndependent statistical analysis of A Study of Subcutaneous Mircera in Participants With Chronic Kidney Disease Not Treated With ESA or on Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning…